Astra Industrial Group announces its Interim Financial results for the Period Ending on 2025-03-31 ( Three Months )

29 April 2025 09:00 AM

ASTRA INDUSTRIAL 1212 -7.17% 146.40 -11.30

Element List	Current Quarter	Similar quarter for previous year	%Change	Previous Quarter	% Change
Sales/Revenue	833,728,170	842,880,387	-1.085	721,601,089	15.538
Gross Profit (Loss)	372,598,003	350,539,320	6.292	330,344,397	12.79
Operational Profit (Loss)	189,301,115	168,460,082	12.371	161,828,003	16.976
Net profit (Loss)	171,871,096	149,741,384	14.778	131,438,601	30.761
Total Comprehensive Income	176,723,126	154,238,486	14.577	135,101,688	30.807
All figures are in (Actual) Saudi Arabia, Riyals

Element List	Current Period	Similar period for previous year	%Change
Total Shareholders Equity (after Deducting Minority Equity)	2,700,529,204	2,282,141,098	18.333
Profit (Loss) per Share	2.15	1.87
All figures are in (Actual) Saudi Arabia, Riyals

Element List	Amount	Percentage of the capital (%)
Profit (Losses) Resulting From The Change In Investment Propertie’s Fair Value	-	-
All figures are in (Actual) Saudi Arabia, Riyals

Element List	Explanation
The reason of the increase (decrease) in the sales/ revenues during the current quarter compared to the same quarter of the last year is	Sales decreases in general due to: Decrease in Sales in the following sectors: a) Steel industry b) Other (comparative period included sales from discontinued operation of Astra Mining)
The reason of the increase (decrease) in the net profit during the current quarter compared to the same quarter of the last year is	Net profit Increases in general due to: 1. Increase in Gross Profit in Pharmaceuticals sector. 2. Decrease in finance costs in the following sector: A. Specialty chemical. B. Other.
The reason of the increase (decrease) in the sales/ revenues during the current quarter compared to the previous one is	Sales increases in general due to: Increase in Sales in the following sectors: a) Pharmaceuticals. b) Steel industry.
The reason of the increase (decrease) in the net profit (loss) during the current quarter compared to the previous one is	Net profit Increases in general due to: 1. Increase Gross Profit in the Pharmaceuticals sector. 2. Decrease in finance costs in following sectors: A. Specialty chemical. B. Other.
Statement of the type of external auditor's report	Unmodified conclusion
Comment mentioned in the external auditor’s report, mentioned in any of the following paragraphs (other matter, conservation, notice, disclaimer of opinion, or adverse opinion)	NA
Reclassification of Comparison Items	Certain comparative figures for the previous period have been reclassified to be consistent with the presentation of the current period.
Additional Information	- Net Shareholders’ Equity at the end of the period was SR 2,707,857,633/- compared to SR 2,284,974,052/- at the end of the similar period last year with an increase of 19%.

Comments